Searched for
SUN PHARMACEUTICAL INC
SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....- Saving supply chains from climate shocks is a lure for investorsCompanies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...
- Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...
- Sun Pharma explores funding mix for $12 billion Organon dealGlobal lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma recalls around 55k bottles of generic medication in USSun Pharma is recalling approximately 55,000 bottles of a generic medication used to treat bowel disease in the US market. The recall is du...
- Sun Pharma, Lupin recall drugs in US market: USFDASun Pharmaceutical is recalling the affected lot that was produced at the drugmaker's Dadra-based facility. The company is recalling the lo...
- Sun Pharma, Aurobindo recall drugs from US marketSun Pharmaceutical Industries and Aurobindo Pharma are recalling products from the US market due to manufacturing issues. Sun Pharma's subs...
- Sun Pharma recalls over 24K prefilled syringes of generic medication in the USIn its latest Enforcement Report, the US Food and Drug Administration (USFDA) noted that the Mumbai-based drug major is recalling 24,194 pr...
- Sun Pharma, Hetero recall drugs in US marketAs per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...
- Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issuesPrinceton (New Jersey) based Sun Pharmaceutical Inc is recalling the affected lot due to "Failed Impurity (Deacetyl Diltiazem Hydrochloride...
- Aurobindo, Sun Pharma recall products in US marketWhile Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Phar...
- Sun Pharma's 2 US arms to pay USD 85 mn in settlement pacts over antritrust litigationUnder the terms of the settlement agreements, the subsidiaries will make an aggregate payment amounting to a combined total of USD 85 milli...
- Sun Pharma, Alembic recall products in US marketAccording to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019.
- Sun Pharma arm picks up 14.6% stake in US company for $13mn"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivale...
- Sun Pharmaceuticals summoned by US Department of JusticeCompany did not elaborate on the summons but such a grand subpoena by the DoJ anti-trust division is usually issued to check anti-competiti...
- Cipher, Ranbaxy settle patent litigation with ActavisCipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litiga...
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL PharmaSun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...
Load More
